.25mg of semaglutide Reduces Heavy Drinking in Obesity and Alcohol Use Disorder | Professor Erwin Loh posted on the topic Semaglutide Pre-Filled Injection 0.25mg |

After the resolution of the deficiency, if patients show clinical or hematologic signs associated with polycythemia vera, it is recommended they undergo further evaluations

(2022) 6:e1728

however, this may be inadequate given the unpredictable effects of these medications on gastric emptying and the extremely long half-lives of the most commonly used GLP-1 agonist medications

Cagrilintide Safety and Risks As with any investigational peptide , cagrilintide should be used with clinical caution , particularly in populations with pre-existing endocrine or gastrointestinal disorders

They compared homes where at least one person reported being on a GLP-1 drug to similar homes where no recent GLP-1 use was reported